Registration Number
2124U012965, Article
popup.category
Текст
Title
Differentiated approach to management of patients with irritable bowel syndrome and ulcerative colitis in non-alcoholic fatty liver disease (AI translated)
popup.author
Дутко Олександр Олександрович
Сірчак Єлизавета Степанівна
Устич Олена Василівна
Лопіт Михайло Михайлович
Грига Василь Іванович
Корнаш Володимир В
Dutko Oleksandr Oleksandrovych
Sirchak Yelyzaveta Stepanivna
Ustych Olena Vasylivna
Lopit Mykhailo Mykhailovych
Hryha Vasyl Ivanovych
Kornash Volodymyr V
popup.publication
01-10-2024
popup.source_user
Ужгородський національний університет
popup.source
https://dspace.uzhnu.edu.ua/jspui/handle/lib/68807
popup.publisher
Aluna Publishing
Description
Aim: To determine the main clinical and laboratory features and severity of colon dysbiosis in irritable bowel syndrome (IBS) and IBD in patients with NAFLD.
Materials and Methods: 80 patients with NAFLD were examined. Patients were divided into two groups. Group 1 (n=40) included patients with NAFLD in combination with ulcerative colitis (UC), and group 2 (n=40) included patients with NAFLD and IBS (clinically manifested by diarrhoea). At patients diagnosed
the level of faecal calprotectin (FC) and a1-antirpsin (a1-AT). Changes in the quantitative and qualitative composition of the colon microflora were assessed.
Results: In both groups of examined patients, a decrease of Bifidobacteria and Lactobacilli, as well as Enterococcus and E. coli with normal enzymatic properties was found compared with the control group. In patients with NAFLD and IBD, an increase in the level of FC was found in 23.8 times compared with the control
group. As expected, there was an increase in the level of a1-AT in the blood serum, faeces and its clearance in patients of group 1.
Conclusions: In patients with NAFLD, both UC and ІBS have similar clinical symptoms. An effective biomarker for differentiating and choosing treatment tactics in patients with NAFLD and UC is the determination of the level of FC.
popup.nrat_date
2026-06-13
